SPPL2A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.172600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.492550E-01
Normal-vs-Stage2
2.722000E-01
Normal-vs-Stage3
1.219820E-02
Normal-vs-Stage4
6.534600E-01
Stage1-vs-Stage2
5.436600E-01
Stage1-vs-Stage3
2.997400E-01
Stage1-vs-Stage4
5.579200E-01
Stage2-vs-Stage3
1.043030E-01
Stage2-vs-Stage4
6.873400E-01
Stage3-vs-Stage4
2.503400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.169200E-01
Normal-vs-AfricanAmerican
4.899800E-01
Normal-vs-Asian
8.980100E-02
Caucasian-vs-AfricanAmerican
3.398800E-01
Caucasian-vs-Asian
3.397000E-01
AfricanAmerican-vs-Asian
1.309200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.978170E-01
Normal-vs-Female
2.596200E-01
Male-vs-Female
4.432600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.333600E-01
Normal-vs-Age(41-60Yrs)
3.979400E-01
Normal-vs-Age(61-80Yrs)
1.866450E-01
Normal-vs-Age(81-100Yrs)
2.138500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.629400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.551600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.123200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.802300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.102400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.363000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.214380E-01
Normal-vs-Daily Drinker
6.465700E-02
Normal-vs-Weekly Drinker
1.865430E-01
Normal-vs-Occasional Drinker
2.138400E-01
Normal-vs-Social Drinker
1.704440E-01
Non Drinker-vs-Daily Drinker
3.455000E-01
Non Drinker-vs-Weekly Drinker
9.085200E-01
Non Drinker-vs-Occasional Drinker
6.184200E-01
Non Drinker-vs-Social Drinker
7.420600E-01
Daily Drinker-vs-Weekly Drinker
5.372600E-01
Daily Drinker-vs-Occasional Drinker
2.050600E-01
Daily Drinker-vs-Social Drinker
2.750200E-01
Weekly Drinker-vs-Occasional Drinker
6.273600E-01
Weekly Drinker-vs-Social Drinker
7.218600E-01
Occasional Drinker-vs-Social Drinker
8.926600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.374000E-01
Normal-vs-Grade 2
5.016100E-02
Normal-vs-Grade 3
5.579900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.865700E-02
Grade 1-vs-Grade 3
6.059300E-03
Grade 1-vs-Grade 4
3.374000E-01
Grade 2-vs-Grade 3
9.369600E-02
Grade 2-vs-Grade 4
5.016100E-02
Grade 3-vs-Grade 4
5.579900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.558850E-01
Normal-vs-NonDiabetic
1.356010E-01
Diabetic-vs-NonDiabetic
9.965000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.688500E-02
Normal-vs-NoPancreatitis
1.530210E-01
Pancreatitis-vs-NoPancreatitis
9.456000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.469810E-01
Normal-vs-N1
2.805200E-01
N0-vs-N1
1.433790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.764800E-01
Normal-vs-TP53-NonMutant
1.983640E-01
TP53-Mutant-vs-TP53-NonMutant
4.260300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
